微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 7.02% | 24.25% | -75.78% | 2/131 | 1.06% | 迈瑞医疗 | 7.06% | 行业排名> |
| 2024-12-31 | 28.99% | 9.48% | 18.86% | 2/131 | 3.1% | 迈瑞医疗 | 31.95% | 行业排名> |
| 2024-09-30 | 24.39% | 8.26% | 55.25% | 2/131 | 4.78% | 迈瑞医疗 | 28.68% | 行业排名> |
| 2024-06-30 | 15.71% | 18.48% | 178.05% | 3/131 | 3.08% | 迈瑞医疗 | 20.2% | 行业排名> |
| 2024-03-31 | 5.65% | 0% | -78.66% | 6/131 | 1.67% | 迈瑞医疗 | 9.12% | 行业排名> |
| 2023-12-31 | 26.48% | 46.87% | 17.53% | 2/131 | 5.12% | 迈瑞医疗 | 33.21% | 行业排名> |
| 2023-09-30 | 22.53% | 55.81% | 69.91% | 2/131 | 5.79% | 迈瑞医疗 | 28.34% | 行业排名> |
| 2023-06-30 | 13.26% | 72.21% | 134.69% | 3/131 | 3.81% | 迈瑞医疗 | 18.36% | 行业排名> |
| 2023-03-31 | 5.65% | 53.53% | -68.66% | 10/131 | 2.29% | 安杰思 | 8.56% | 行业排名> |
| 2022-12-31 | 18.03% | 71.39% | 24.69% | 31/131 | 13.36% | 九安医疗 | 146.56% | 行业排名> |
| 2022-09-30 | 14.46% | 38.51% | 87.79% | 34/131 | 12.77% | 九安医疗 | 140.94% | 行业排名> |
| 2022-06-30 | 7.7% | 12.74% | 109.24% | 46/131 | 9.3% | 九安医疗 | 142.25% | 行业排名> |
| 2022-03-31 | 3.68% | -2.39% | -65.02% | 40/131 | 6.26% | 九安医疗 | 142.71% | 行业排名> |
| 2021-12-31 | 10.52% | -56.42% | 0.77% | 78/131 | 17.4% | 热景生物 | 121.78% | 行业排名> |
| 2021-09-30 | 10.44% | -38.33% | 52.86% | 58/131 | 15.94% | 热景生物 | 99.69% | 行业排名> |
| 2021-06-30 | 6.83% | -30.38% | 81.17% | 58/131 | 11.54% | 热景生物 | 99.09% | 行业排名> |
| 2021-03-31 | 3.77% | 2% | -84.38% | 42/131 | 6.23% | 热景生物 | 57.63% | 行业排名> |
| 2020-12-31 | 24.14% | -6.87% | 42.59% | 38/131 | 25.69% | 中红医疗 | 168% | 行业排名> |
| 2020-09-30 | 16.93% | 2% | 72.58% | 33/131 | 19.85% | 圣湘生物 | 112.46% | 行业排名> |
| 2020-06-30 | 9.81% | 2% | -62.15% | 44/131 | 15.16% | 博拓生物 | 108.13% | 行业排名> |
| 2019-12-31 | 25.92% | 44% | 44% | 23/131 | 14.38% | 圣湘生物 | 29.33% | 行业排名> |
| 2018-12-31 | 18% | 241.56% | 241.56% | 38/131 | 12.98% | 健尔康 | 84.09% | 行业排名> |
| 2017-12-31 | 5.27% | 2% | 2% | 78/131 | 13.82% | 祥生医疗 | 28.56% | 行业排名> |